PLA2G2A and myeloid sarcoma: In a previous study, the intervention of a mixture of hempseed oil (HSO) and evening primrose oil (EPO) with ω6/ω3 EFAs (with a ratio of 2.3:1) in relapsing-remitting (RR) MS patients could down-regulate D6D, and phospholipases A2(PLA2) expression.